Cosmos Health Advances Weight Management Hydrogel Patent Globally

Cosmos Health Inc. announced that its subsidiary, Cana Laboratories S.A., has advanced the international patent application WO2025108566A1 for its proprietary hydrogel technology, CCX0722, into the U.S., European, Australian, and Canadian national phases. This move follows Cana's recent acquisition of the patent application from Cloudpharm, granting Cosmos Health full ownership of the intellectual property for the weight management product. The company highlights the significant market opportunity, with the global weight management market projected to grow from $190.6 billion in 2025 to $562.2 billion by 2033.